Study to evaluate the pain-relieving effect of Shilajit in patients with Myofascial pain syndrome

EXPLORATORY PILOT CLINICAL TRIAL ON NATIVE SHILAJIT AS AN ANALGESIC IN MYOFASCIAL PAIN SYNDROME - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088636

Enrollment

Registered

2025-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M791- Myalgia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with VAS more than 4 Patients who give consent to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Percentage reduction in Visual Analog Scale (VAS) score from baseline (Day 0) to Day 24 and Day 49.Timepoint: Percentage reduction in Visual Analog Scale (VAS) score from baseline (Day 0) to Day 24 and Day 49.	—

Secondary

Measure	Time frame
To assess the safety profile of native Himalayan Shilajit by monitoring and documenting any adverse effects throughout the study period.Timepoint: DAY 24 AND DAY 49	—

Countries

India

Contacts

Public ContactDarshan B

All India Institute ,of Medical sciences, Rishikesh,Uttarakhand

prasan.med@aiimsrishikesh.edu.in9868999488

Outcome results